Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903. Have a read: https://www.m3india.in/contents/journal/phase-2-study-of-anastrozole-in-recurrent-estrogen-er-progesterone-pr-2?utm_campaign=unset&utm_medium=share&utm_source=ref_wa